Republic of Moldova vs Western Pacific (WHO region): Previously treated cases tested for RR-/MDR-TB
Republic of Moldova
100.0%
in 2024
Western Pacific (WHO region)
86.0%
in 2024
Republic of Moldova rank
1st
Western Pacific (WHO region) rank
3rd
Previously treated cases tested for RR-/MDR-TB over time
- Republic of Moldova
- Western Pacific (WHO region)
How they compare
Republic of Moldova currently reports 100.0% against 86.0% in Western Pacific (WHO region), a difference of 14.0%.
That makes Republic of Moldova's figure about 1.2 times Western Pacific (WHO region)'s.
The two have swapped places 4 times across 20 shared years of data; in 2005 it was Republic of Moldova ahead.
Republic of Moldova ranks 1st and Western Pacific (WHO region) ranks 3rd of 180 countries.
Republic of Moldova has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Republic of Moldova | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 62.6% | 1.0% | 61.6% | Republic of Moldova |
| 2010s | 63.6% | 54.9% | 8.7% | Republic of Moldova |
| 2020s | 97.2% | 89.2% | 8.0% | Republic of Moldova |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Republic of Moldova or Western Pacific (WHO region)?
- Republic of Moldova, at 100.0% against 86.0% in Western Pacific (WHO region) as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Republic of Moldova and Western Pacific (WHO region)?
- 14.0%, with Republic of Moldova ahead.
- How many years of comparable data are there for Republic of Moldova and Western Pacific (WHO region)?
- 20 years are reported by both, from 2005 to 2024.
- How do Republic of Moldova and Western Pacific (WHO region) rank globally for previously treated cases tested for rr-/mdr-tb?
- Republic of Moldova ranks 1st and Western Pacific (WHO region) ranks 3rd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.